Published in TB and Outbreaks Week, May 10th, 2005
In a study from Spain, scientists evaluated the antimicrobial efficacy of ramoplanin - which "inhibits cell wall synthesis by acting at the level of lipid intermediate formation" - in C. difficile cultures.
"We included strains with reduced susceptibilities to vancomycin (vancomycin-intermediate [Vani] strains) or with resistance to metronidazole (Mtzr), in order to assess the potential utility of ramoplanin for the treatment of C. difficile-associated diarrhea," explained T. Pelaez and coauthors at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week